Literature DB >> 34269921

Intersection Between Chronic Kidney Disease and Cardiovascular Disease.

Luke J Laffin1, George L Bakris2.   

Abstract

PURPOSE OF REVIEW: The incidence of chronic kidney disease is increasing worldwide, and the previously decreasing incidence of cardiovascular disease has now plateaued. Understanding the intersection of both heart and kidney disease is crucial. RECENT
FINDINGS: Chronic kidney disease and cardiovascular disease share common risk factors and specific pathogenic mechanisms and impact a significant segment of the population. Patients with chronic kidney disease are more likely to have cardiovascular disease than progress to end-stage kidney disease requiring renal replacement therapy. We discuss shared risk factors and mechanisms for cardiovascular and chronic kidney disease. The following also addresses contemporary cardiovascular treatment considerations in patients with chronic kidney disease with a focus on atherosclerotic cardiovascular disease and heart failure.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular disease; Chronic kidney disease; Heart failure

Mesh:

Year:  2021        PMID: 34269921     DOI: 10.1007/s11886-021-01546-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  67 in total

1.  Chronic kidney disease and life expectancy.

Authors:  Tanvir Chowdhury Turin; Marcello Tonelli; Braden J Manns; Pietro Ravani; Sofia B Ahmed; Brenda R Hemmelgarn
Journal:  Nephrol Dial Transplant       Date:  2012-03-22       Impact factor: 5.992

2.  Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.

Authors:  Finlay A McAlister; Justin Ezekowitz; Luigi Tarantini; Iain Squire; Michel Komajda; Antoni Bayes-Genis; Israel Gotsman; Gillian Whalley; Nikki Earle; Katrina K Poppe; Robert N Doughty
Journal:  Circ Heart Fail       Date:  2012-03-22       Impact factor: 8.790

3.  Proteinuria and life expectancy.

Authors:  Tanvir Chowdhury Turin; Marcello Tonelli; Braden J Manns; Sofia B Ahmed; Pietro Ravani; Matthew James; Brenda R Hemmelgarn
Journal:  Am J Kidney Dis       Date:  2012-12-08       Impact factor: 8.860

Review 4.  Chronic kidney disease as a coronary artery disease risk equivalent.

Authors:  Alexandrios Briasoulis; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

5.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

6.  Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.

Authors:  Nisha Bansal; Ronit Katz; Cassianne Robinson-Cohen; Michelle C Odden; Lorien Dalrymple; Michael G Shlipak; Mark J Sarnak; David S Siscovick; Leila Zelnick; Bruce M Psaty; Bryan Kestenbaum; Adolfo Correa; Maryam Afkarian; Bessie Young; Ian H de Boer
Journal:  JAMA Cardiol       Date:  2017-03-01       Impact factor: 14.676

7.  Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

Authors:  Finlay A McAlister; Justin Ezekowitz; Marcello Tonelli; Paul W Armstrong
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

Review 8.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

Review 9.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Authors:  Bakhtawar K Mahmoodi; Kunihiro Matsushita; Mark Woodward; Peter J Blankestijn; Massimo Cirillo; Takayoshi Ohkubo; Peter Rossing; Mark J Sarnak; Bénédicte Stengel; Kazumasa Yamagishi; Kentaro Yamashita; Luxia Zhang; Josef Coresh; Paul E de Jong; Brad C Astor
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Authors:  Caroline S Fox; Kunihiro Matsushita; Mark Woodward; Henk J G Bilo; John Chalmers; Hiddo J Lambers Heerspink; Brian J Lee; Robert M Perkins; Peter Rossing; Toshimi Sairenchi; Marcello Tonelli; Joseph A Vassalotti; Kazumasa Yamagishi; Josef Coresh; Paul E de Jong; Chi-Pang Wen; Robert G Nelson
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

View more
  4 in total

1.  Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.

Authors:  João Pedro Ferreira; Faiez Zannad; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Martina Brueckmann; Dominik Steubl; Elke Schueler; Stefan D Anker; Milton Packer
Journal:  JAMA Cardiol       Date:  2022-09-21       Impact factor: 30.154

2.  Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study.

Authors:  Zhiyao Bao; Lifeng Luo; Tian Xu; Jin Yang; Mengchen Lv; Lei Ni; Xianwen Sun; Wei Chen; Lin Zhou; Xiaofei Wang; Yi Xiang; Beili Gao
Journal:  Ann Transl Med       Date:  2022-09

Review 3.  Value of SGLT-2 inhibitors in the treatment of chronic kidney disease : Clinical and practical implications.

Authors:  Marcus Säemann; Daniel Cejka; Sabine Schmaldienst; Alexander R Rosenkranz; Gert Mayer
Journal:  Wien Klin Wochenschr       Date:  2022-10-17       Impact factor: 2.275

4.  Analysis of the Effectiveness of the Nurse-Led "Outpatient-Ward-Home" Management Model in Chronic Kidney Patients.

Authors:  Qi Hu; Xue Yang; Wei Wang; Man Meng
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.